CordenPharma invests €900M in expanding peptide platform to meet GLP-1 drug demand 18-Jul-2024 By Clara Rodriguez Fernandez CordenPharma, a US-based contract development and manufacturing organization (CDMO), will be making a €900 million investment over the next three years into expanding its peptide technology platform at its US and Europe sites.